Fig 2. Kaplan Meier curves for the composite outcome in patients who received Bebtelovimab monoclonal antibody treated group vs. not-treated control group between April 5, 2022, and August 1, 2022.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.